PANCREASaver®
Product overview and a guided discussion of the review workflow.
CHICAGO · NOV 29–DEC 2, 2026
Meet PanCAD.ai at RSNA 2026
Visit our team at Booth 5132 to learn how PANCREASaver® flags suspicious pancreatic findings on contrast-enhanced abdominal CT for radiologist review.
WHEREMcCormick Place, Chicago
TECHNICAL EXHIBITSNov 29–Dec 2 · 10 a.m.–5 p.m. CT
WHAT TO DISCUSS
One conversation, tailored to your workflow.
PanCAD.ai is a Taiwan-based medical AI company developing PANCREASaver®, software for AI-assisted review of pancreatic findings on CT. Meet our team to explore product information, published evidence, clinical workflows, and possible collaborations.
U.S. regulatory status: FDA 510(k) submission pending; PANCREASaver® is not cleared for U.S. marketing. AI output supports physician review and does not make an independent diagnosis.
Clinical evidence
Study context, published findings, and appropriate clinical use.
Integration & partnership
PACS/RIS/DICOM workflow, distribution, research, or strategic fit.
BOOTH 5132 · RSNA 2026
Schedule a conversation with PanCAD.ai.
Tell us who you are and what you would like to explore. Our team will follow up by email to confirm an available meeting time.
Please do not include patient information or medical images in this form.